₹334.25▼ −8.35 · −2.4%from ₹342.60 the session before · 10 Aug 2026 close · NSE end of day
Open
₹339.90
High
₹345.00
Low
₹326.00
Day's range
₹195.5% of the previous close
VWAP
₹332.34close +0.57% from it
Volume, shares
32,0000.36× the 20-session average
Turnover, ₹ crore
1.1
Trades
1,90017 shares per trade
Previous close
₹342.60−8.35 to the close
Price band, next session
₹300.80 – ₹367.7010% either side of the close · dynamic, widened in 5% steps when hit
Day range43% of the way up
₹326.00₹345.00
52-week range87% of the way up
₹204.00 30 Mar₹354.00 6 Aug
−5.6% from the high · +64% from the low
Futures and options
No derivatives listed on NURECA
Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 10 Aug · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
Revenue ₹40 cr; profit ₹3 cr in the Jun 2026 quarter, consolidated.
Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of NURECA on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue ₹ cr
Revenue YoY
Profit ₹ cr
Profit YoY
EPS ₹
Market on the day
Jun 2026filed 21 Jul
₹40 cr
—
₹3 cr
—
3.21
▲ +6.5%Nifty −0.8% · +7.3 pp
Mar 2026filed 31 Mar · audited
₹35 cr
—
−₹6 cr
—
-6.45
▲ +10.0%Nifty +1.6% · +8.4 pp
Fundamentals
consolidated · filings to Jun 2026 · close ₹334.25 on 10 Aug
Fundamentals for NURECA on the consolidated basis to Jun 2026.
Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
—no NSE market-cap record yet
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
—no NSE market-cap record yet
Book value a share
—no NSE share count yet
Debt to equity
0.00borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
—no NSE record yet
Shares outstanding
—no NSE record yet
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Medical Equipment & Supplies · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Medical Equipment & Supplies with market cap, price to earnings and price to book
Promoters hold 68.1%, foreign portfolio investors 0.1%, banks and financial institutions 0.2% and individual investors 30.0%, as filed for the quarter to 30 Jun.
68.1%30.0%
Promoters 68.1%
Foreign portfolio investors 0.1%
Banks and financial institutions 0.2%
Individual investors 30.0%
Others 1.6%
By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of NURECA by category over the last 2 quarters with the change against the previous quarter
Category
30 Jun
31 Mar
Promoters
68.090.00 pp
68.09
Foreign portfolio investors
0.11▼ −0.17 pp
0.28
Banks and financial institutions
0.240.00 pp
0.24
Individual investors
29.96▲ +0.25 pp
29.71
Bodies corporate
0.59▼ −0.04 pp
0.63
Others
1.02▼ −0.03 pp
1.05
Corporate actions
NSE and BSE records
Nothing upcoming on record; the last was a buyback, ex-date 12 Dec 2025.
Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of NURECA, upcoming first, then the most recent
Ex-date
Action
Amount or ratio
Record date
Source
recent
12 Dec 2025
buyback
—
12 Dec 2025
NSE
11 Jul 2024
otherAnnual General Meeting
—
—
NSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
—a share · ex-dates inside the year
Last dividend
—none on record
Price history
213 sessions on record · to 10 Aug · NSE end of day
NURECA is +36.1% over 20 sessions against Nifty's +1.5%, 5.6% below its 52-week high, realised volatility 64% annualised.
Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
Window
From ₹
NURECA %
Nifty 50 %
Difference pp
120 sessionssince 11 Feb
₹283.05
▲ +18%
▼ −5.3%
+23
60 sessionssince 14 May
₹271.24
▲ +23%
▲ +3.8%
+19
20 sessionssince 13 Jul
₹245.57
▲ +36%
▲ +1.5%
+35
5 sessionssince 3 Aug
₹333.42
▲ +0.25%
▼ −0.77%
+1.0
1 sessionsince 7 Aug
₹342.61
▼ −2.4%
▲ +0.05%
−2.5
Averages of the closeclose against each average
5-session average
₹337.10close −0.85% from it
20-session average
₹311.05close +7.5% from it
50-session average
₹265.22close +26% from it
200-session average
₹270.56close +24% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹195.8% of the close
Average day's range, 20
₹216.4% of the close
Volume against 20 sessions
0.36×32,000 vs 90,000 average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
64%≈ ±4.0% a session · moved more than that on 7 of 20
Realised volatility, 60
54%≈ ±3.4% a session · moved more than that on 10 of 60
Beta to Nifty, 60
0.48moved with Nifty on 33 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
12 up · 8 downof 20
Last 60 sessions
33 up · 27 downof 60
Best session, 250
▲ +19%17 Oct
Worst session, 250
▼ −15%1 Jun
0 bulletins on NURECA
The desk has not written about Nureca Limited yet. The tape carries every bulletin as it is published.
About Nureca Limited
exchange masters as of 18 Sept 2026 · classification by BSE
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 01:04 am IST
Bulletins
0 · written by the desk · not a recommendation
OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.